Synopsys, a key software provider for advanced AI chips, is trading at a lower valuation than its peers despite strong revenue growth and raised earnings guidance. Shares recently jumped 10.6% following a new AI partnership and analyst upgrades, with a price target suggesting nearly 30% upside in the next year. The company benefits from expanding AI chip design demand and new royalty-based deals, though risks include debt levels and geopolitical factors. Investor Day on September 30 is a key upcoming event that could confirm growth prospects.
Synopsys shares on Pluang are priced at USD 419.31 as of September 29, 2026, down 1.51% for the day, trading closer to their 52-week low of USD 367.70 than the high of USD 534.56. This positions Synopsys at a valuation discount relative to its recent peak despite the positive news and analyst upgrades mentioned. The stock's market cap stands at $81.59 billion, reflecting its significant role in the technology sector as investors await further clarity from the upcoming Investor Day event.
Synopsys introduced the Autopilot Platform featuring AgentEngineer AI solutions that automate complex engineering workflows from silicon to systems. This platform enhances productivity, design quality, and verification speed by leveraging domain-spec...
HSBC upgraded Synopsys from hold to buy, raising its price target to $700, citing a shift to a royalty-based business model that could boost earnings growth to 28% annually through 2028. This change positions Synopsys as a key AI growth player, with ...
